| 发明名称 |
PHARMACEUTICAL COMPOSITIONS |
| 摘要 |
The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention. |
| 申请公布号 |
US2014228288(A1) |
申请公布日期 |
2014.08.14 |
| 申请号 |
US201414261602 |
申请日期 |
2014.04.25 |
| 申请人 |
GlaxoSmithKline, LLC |
发明人 |
BUSH Mark A.;Stewart Murray W.;Yang Yonghong |
| 分类号 |
A61K38/26 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:1 wherein an effective dose of said pharmaceutical composition comprises 50 mg of said polypeptide. |
| 地址 |
Wilmington DE US |
